Topic

GLP-1 Weight Loss

7 articles on GLP-1 Weight Loss, written by Shotlee and medically reviewed for clinical accuracy.

Lost 9 Stone on Mounjaro: Loose Skin Sparks ElastiK Skin Business
GLP-1 Medications

Lost 9 Stone on Mounjaro: Loose Skin Sparks ElastiK Skin Business

Marc McKee dropped nine stone with Mounjaro, transforming his health but leaving him with loose skin that inspired a new business. ElastiK Skin targets GLP-1 weight loss side effects using peptides, hyaluronic acid, and LED therapy. Early users report better hydration and elasticity with consistent use.

5 min read
Ozempic Fuels Tapatío Hot Sauce Boom: L.A. Icon's Story
GLP-1 Medications

Ozempic Fuels Tapatío Hot Sauce Boom: L.A. Icon's Story

Ozempic isn't just transforming waistlines—it's igniting a surge in hot sauce sales like Tapatío's. As millions embrace GLP-1 drugs, cravings for bold flavors skyrocket, propelling L.A.'s iconic brand into national expansion under new owners Highlander Partners. This is the untold story of family legacy meeting metabolic health trends.

5 min read
Amazon Adds Same-Day Delivery for GLP-1 Drug Foundayo
GLP-1 Medications

Amazon Adds Same-Day Delivery for GLP-1 Drug Foundayo

Amazon is revolutionizing access to GLP-1 weight-loss drugs by launching same-day delivery for Foundayo through Amazon Pharmacy in nearly 3,000 cities. Patients can now order with a valid prescription, check real-time availability, and get medication home-delivered faster than traditional options. This move cuts treatment barriers from prescription to doorstep.

4 min read
Behavioral Adherence Tools Key to GLP-1 Weight Loss Success: New Data
GLP-1 Medications

Behavioral Adherence Tools Key to GLP-1 Weight Loss Success: New Data

As GLP-1 medication use surges, a Weight Watchers report reveals medication alone isn't enough for lasting weight loss. Weight Loss Buddy emerges as a vital tool, combining AI-driven guidance and peer accountability to boost adherence and outcomes. This shift highlights the need for behavioral infrastructure in obesity treatment.

4 min read
Gemma Collins Sells Clothes on Vinted After 3 Stone Mounjaro Loss
Celebrity Weight Loss Stories

Gemma Collins Sells Clothes on Vinted After 3 Stone Mounjaro Loss

Millionaire Gemma Collins is flogging her once-worn clothes on Vinted after shedding 3 stone with Mounjaro injections. From size 26 to 20, the TOWIE star shares how the jabs curbed her food obsession. But a gallbladder scare paused her treatment—here's her full story.

6 min read
Joy Behar Reveals GLP-1 Weight Loss: 'I Was Prediabetic' on The View
GLP-1 Medications

Joy Behar Reveals GLP-1 Weight Loss: 'I Was Prediabetic' on The View

On The View, Joy Behar opened up about her GLP-1 weight loss success, noting she was prediabetic before starting. Co-host Sunny Hostin shared gaining 40 lbs during COVID and using Mounjaro to improve her cholesterol from 200 to 140. These stories highlight Hollywood's trend toward Ozempic and similar drugs for real health gains.

5 min read
Lilly Stockpiles $1.5B Orforglipron Ahead of FDA Approval Signal
GLP-1 Medications

Lilly Stockpiles $1.5B Orforglipron Ahead of FDA Approval Signal

Eli Lilly is sending a clear signal of confidence in its upcoming GLP-1 obesity pill, orforglipron, by stockpiling $1.5 billion worth of inventory ahead of FDA approval. This move, up from $550 million last year, anticipates robust demand without the supply chain issues that plagued injectables like Wegovy from 2022-2024. Here's what it means for patients seeking oral weight loss options.

5 min read